ACR Meeting Abstracts

ACR Meeting Abstracts

  • Home
  • Meetings Archive
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018 ACR/ARHP Annual Meeting
    • 2017-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • Meeting Resource Center

Abstract Number: 268

TLR4 Endogenous Ligand S100A8/A9 Levels in Adult-Onset Still’s Disease and Their Association with Disease Activity and Clinical Manifestations

Hyoun-Ah Kim1, In Je Kim2, Jae Ho Han3, Juyang Jung4, Chang-Hee Suh4 and You-Sun Kim5, 1Department of Rheumatology, Ajou University School of Medicine, Suwan, South Korea, 2Division of Rheumatology, Department of Internal Medicine, Ewha Womans University School of Medicine, Seoul, South Korea, 3Department of Pathology, Ajou University School of Medicine, Suwon, South Korea, 4Department of Rheumatology, Ajou University School of Medicine, Suwon, South Korea, 5Department of Biochemistry and Molecular biology, Ajou University School of Medicine, Suwon, South Korea

Meeting: 2015 ACR/ARHP Annual Meeting

Date of first publication: September 29, 2015

Keywords: Adult-onset Still's disease

  • Tweet
  • Email
  • Print
Session Information

Date: Sunday, November 8, 2015

Session Title: Miscellaneous Rheumatic and Inflammatory Diseases Poster I

Session Type: ACR Poster Session A

Session Time: 9:00AM-11:00AM

Background/Purpose: S100A8 and S100A9 are two calcium-binding proteins that belong to the S100 family, and those are expressed by infiltrating monocytes and neutrophils under inflammatory conditions.  S100A8/A9 has been suggested as biomarkers of disease activity in patients with systemic juvenile idiopathic arthritis or adult-onset Still’s disease (AOSD). We investigated the clinical significance and the pathogenic role of this marker in AOSD.

Methods: Serum samples were prospectively collected from 20 active AOSD patients, 20 rheumatoid arthritis (RA), and 20 healthy controls (HC). S100A8/A9 expression levels in biopsy specimens obtained from 26 AOSD patients with skin rashes and 8 AOSD with lymphadenopathy were investigated via immunohistochemistry. Each marker was recorded as the numbers of positive inflammatory cells divided by the numbers of total inflammatory cells, then expressed as a graded on a scale from 1 to 3: 1,1-33%; 2, 34-66%,; 3, 67-100%. Peripheral blood mononuclear cells (PBMC) from active AOSD and HC were evaluated for interleukin-1β (IL-1β) release, and in vitro study with PBMC and human acute monocytic leukemia (THP-1) cell line was done for cell signal of S100A9 or S100A8/A9.

Results: S100A8/A9 levels of active AOSD (15.43 ± 7.3 μg/mL) were higher than those of RA (4.04 ± 4.18 μg/mL, p<0.001) and HC (2.01 ± 1.06 μg/mL, p<0.001). The IL-1β and TNF- α levels of AOSD were higher than those of HC. Serum S100A8/A9 levels correlated with IL-1β (r=0.603, p<0.001), TNF- α (r=0.405, p=0.009), ferritin (r=0.698, p<0.001), and CRP (r=0.811, p<0.001). The grade of inflammatory cells expressing S100A8/A9 ranged variably from 1 to 3 in skin and lymph node biopsies of active AOSD. The grading and strength of staining of the positive cells in S100A8/A9 was more intense for karyrrhexis (p=0.028), mucin deposition (p=0.014), and neutrophil infiltration (p=0.006). S100A9 in serum of patients with AOSD was a strong inducer of IL-1β expression in PBMC. S100A9 induced signal transduction pathways, including JNK and p38 in PBMC from AOSD patients and HC.

Conclusion: The data suggest that S100A8/A9 may contribute to the inflammatory response by induction of inflammatory cytokines, and serve as clinicopathologic markers for assessment of disease activity in AOSD.


Disclosure: H. A. Kim, None; I. J. Kim, None; J. H. Han, None; J. Jung, None; C. H. Suh, None; Y. S. Kim, None.

To cite this abstract in AMA style:

Kim HA, Kim IJ, Han JH, Jung J, Suh CH, Kim YS. TLR4 Endogenous Ligand S100A8/A9 Levels in Adult-Onset Still’s Disease and Their Association with Disease Activity and Clinical Manifestations [abstract]. Arthritis Rheumatol. 2015; 67 (suppl 10). https://acrabstracts.org/abstract/tlr4-endogenous-ligand-s100a8a9-levels-in-adult-onset-stills-disease-and-their-association-with-disease-activity-and-clinical-manifestations/. Accessed March 23, 2023.
  • Tweet
  • Email
  • Print

« Back to 2015 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/tlr4-endogenous-ligand-s100a8a9-levels-in-adult-onset-stills-disease-and-their-association-with-disease-activity-and-clinical-manifestations/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

ACR Pediatric Rheumatology Symposium 2020

© COPYRIGHT 2023 AMERICAN COLLEGE OF RHEUMATOLOGY

Wiley

  • Home
  • Meetings Archive
  • Advanced Search
  • Meeting Resource Center
  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences